Irene González Martínez

Title: Innovations of Irene González Martínez

Introduction

Irene González Martínez is a notable inventor based in Valencia, Spain. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-based therapies. Her work focuses on the modulation of microRNAs, which play crucial roles in various biological processes.

Latest Patents

Irene holds a patent for "Oligonucleotides conjugated to oleic acid and uses thereof." This invention provides oligonucleotide and/or oligonucleotide analogue molecules that act as antagonists of specific human microRNAs, namely hsa-miR-23b-3p and hsa-miR-218-5p. These molecules comprise a mixture of phosphorothioate and phosphodiester linkages and are conjugated to oleic acid. By inhibiting these microRNAs, her invention aims to increase the endogenous levels of the corresponding proteins MBNL1 and/or MBNL2. The patent also includes compositions comprising these oligonucleotides and their applications for the treatment and prevention of diseases in subjects in need.

Career Highlights

Irene has worked with esteemed institutions such as Universitat De Valencia and Arthex Biotech S.L. Her research and innovations have contributed to advancements in therapeutic strategies, particularly in the context of microRNA modulation.

Collaborations

Irene has collaborated with notable colleagues, including Rubén Artero Allepuz and Nerea Moreno Cervera. These partnerships have enhanced her research efforts and broadened the impact of her inventions.

Conclusion

Irene González Martínez is a pioneering inventor whose work in oligonucleotide therapies showcases the potential of biotechnology in addressing complex medical challenges. Her contributions continue to influence the field and inspire future innovations.